NO773245L - Fremgangsmaate for fremstilling av nye triazolopyridaziner - Google Patents

Fremgangsmaate for fremstilling av nye triazolopyridaziner

Info

Publication number
NO773245L
NO773245L NO773245A NO773245A NO773245L NO 773245 L NO773245 L NO 773245L NO 773245 A NO773245 A NO 773245A NO 773245 A NO773245 A NO 773245A NO 773245 L NO773245 L NO 773245L
Authority
NO
Norway
Prior art keywords
hydrogen
methyl
trifluoromethyl
group
formula
Prior art date
Application number
NO773245A
Other languages
English (en)
Norwegian (no)
Inventor
George Rodger Allen
John William Hanifin
Daniel Bryan Moran
Jay Donald Albright
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/725,597 external-priority patent/US4230705A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO773245L publication Critical patent/NO773245L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO773245A 1976-09-22 1977-09-21 Fremgangsmaate for fremstilling av nye triazolopyridaziner NO773245L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/725,597 US4230705A (en) 1976-09-22 1976-09-22 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
US73039576A 1976-10-07 1976-10-07
US73547576A 1976-10-26 1976-10-26

Publications (1)

Publication Number Publication Date
NO773245L true NO773245L (no) 1978-03-28

Family

ID=27419081

Family Applications (1)

Application Number Title Priority Date Filing Date
NO773245A NO773245L (no) 1976-09-22 1977-09-21 Fremgangsmaate for fremstilling av nye triazolopyridaziner

Country Status (19)

Country Link
JP (1) JPS5340798A (de)
AR (2) AR218036A1 (de)
AT (1) AT360034B (de)
AU (1) AU513760B2 (de)
BG (1) BG29287A3 (de)
CA (1) CA1080712A (de)
DD (1) DD132586A5 (de)
DE (1) DE2741763A1 (de)
DK (1) DK417377A (de)
ES (3) ES462543A1 (de)
FI (1) FI772802A (de)
FR (1) FR2442848A1 (de)
GB (1) GB1589237A (de)
GR (1) GR71699B (de)
LU (1) LU78150A1 (de)
NL (1) NL7710389A (de)
NO (1) NO773245L (de)
PT (1) PT67067B (de)
RO (1) RO72226A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR70309B (de) * 1979-10-29 1982-09-08 Dow Chemical Co
FR2473522A1 (fr) * 1980-01-16 1981-07-17 Synthelabo Nouveaux derives substitues de dihydro-2,3 imidazo(1,2-b)pyridazines et les medicaments, utiles notamment comme antidepresseurs, qui en contiennent
EP0036711B1 (de) * 1980-03-22 1985-12-04 Fbc Limited Heterocyclische pestizide Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende Zusammensetzungen und ihre Verwendung
DE3217325A1 (de) * 1982-05-08 1983-11-10 Hoechst Ag, 6230 Frankfurt 3-amino-6-aryl-1,2,4-triazolo(4,3-b)-pyridazine, ihre herstellung und ihre verwendung
US4487930A (en) * 1982-09-07 1984-12-11 The Dow Chemical Company 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines
FR2562071B1 (fr) * 1984-03-30 1986-12-19 Sanofi Sa Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
US4767765A (en) * 1985-10-31 1988-08-30 American Cyanamid Company N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
US4654343A (en) * 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
PL331072A1 (en) 1996-07-25 1999-06-21 Merck Sharp & Dohme Substututed derivatives of triazolo-pyrydazine as ligands for gaba receptors
AU746866B2 (en) * 1998-01-14 2002-05-02 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801210D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
CN1110498C (zh) 1998-01-21 2003-06-04 默克·夏普-道姆公司 作为gaba受体的配体的三唑并－哒嗪衍生物
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) * 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
EP1719756A4 (de) * 2004-02-18 2007-09-26 Banyu Pharma Co Ltd Derivat mit stickstoffhaltigem, kondensierten heteroaromatischen ring
CA3045121A1 (en) * 2016-11-28 2018-05-31 Praxis Precision Medicines, Inc. Compounds and their methods of use
US11866439B2 (en) 2018-05-30 2024-01-09 Praxis Precision Medicines, Inc. Ion channel modulators
US11773099B2 (en) 2019-05-28 2023-10-03 Praxis Precision Medicines, Inc. Compounds and their methods of use
US11505554B2 (en) 2019-05-31 2022-11-22 Praxis Precision Medicines, Inc. Substituted pyridines as ion channel modulators

Also Published As

Publication number Publication date
FR2442848A1 (fr) 1980-06-27
CA1080712A (en) 1980-07-01
ES462543A1 (es) 1979-06-16
PT67067B (en) 1979-02-19
DE2741763A1 (de) 1978-03-23
PT67067A (en) 1977-10-01
AU2899577A (en) 1979-03-29
JPS5340798A (en) 1978-04-13
AU513760B2 (en) 1980-12-18
AR218036A1 (es) 1980-05-15
GB1589237A (en) 1981-05-07
GR71699B (de) 1983-06-21
AR217886A1 (es) 1980-04-30
ES477800A1 (es) 1979-10-16
FI772802A (fi) 1978-03-23
DK417377A (da) 1978-03-23
LU78150A1 (de) 1978-01-23
RO72226A (ro) 1982-09-09
AT360034B (de) 1980-12-10
ATA677577A (de) 1980-05-15
NL7710389A (nl) 1978-03-28
ES477799A1 (es) 1980-04-01
DD132586A5 (de) 1978-10-11
BG29287A3 (en) 1980-10-15

Similar Documents

Publication Publication Date Title
NO773245L (no) Fremgangsmaate for fremstilling av nye triazolopyridaziner
US4112095A (en) 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
US4230705A (en) 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
Evans et al. Synthesis and antihypertensive activity of substituted trans-4-amino-3, 4-dihydro-2, 2-dimethyl-2H-1-benzopyran-3-ols
KR900004833B1 (ko) N-치환-N-[3-(1,2,4-트리아졸로[4,3-b]피리다진-6-일)페닐]알칸아미드, 카바메이트 및 우레아 화합물과 그 제조 방법 및 조성물
CA1234114A (en) 3,6-disubstituted triazolo¬3,4-a|phthalazine derivatives
NO851862L (no) Fremgangsmaate ved fremstilling av nye pyrrolobenzimidazoler
US4260755A (en) Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines
EP1149102A1 (de) Triazolopyridazinderivate als liganden für gaba-rezeptoren
EP0029103B1 (de) 6- und 8-Heteroaryl-1,2,4-triazol(4,3-b)pyridazine
WO1999037644A1 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
CA1305703C (en) 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo-[1,5-a] pyrimidines
AU748013B2 (en) Triazolo-pyridazine derivatives as ligands for GABA receptors
US4117130A (en) Method for treating anxiety in mammals
US6262045B1 (en) 4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy
TW200837065A (en) Protein kinase inhibitors
NO156011B (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 3, 6, 7, 8-substituerte-s-triazolo (4,3-b) pyridaziner.
US4569934A (en) Imidazo[1,2-b]pyridazines
EP1056748A1 (de) Triazolo-pyridazin- derivate als liganden für gaba rezeptoren
Behbehani et al. Microwave-assisted Synthesis in Water: First One-pot Synthesis of a Novel Class of Polysubstituted benzo [4, 5] imidazo [1, 2-b] pyridazines via Intramolecular SN Ar
Biagi et al. New 1, 2, 3‐triazolo [4, 5‐d] 1, 2, 4‐triazolo [3, 4‐b] pyridazine derivatives II
WO2000047582A1 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
US4482714A (en) Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives
DD215545A5 (de) Verfahren zur herstellung eines (1,2,4)triazolo (4,3-a)chin-oxalin-4-amin-derivats
US4767765A (en) N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas